32864-11-2

Basic information

• Product Name: Benzaldehyde, 2-chloro-3,4-dihydroxy-
• CAS NO: 32864-11-2
• Molecular Formula: C7H5ClO3
• Molecular Weight: 172.568
• Mol File: 32864-11-2.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 2-chloro-3,4-dihydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 2-chloro-3,4-dihydroxy-(32864-11-2)
• EPA Substance Registry System: Benzaldehyde, 2-chloro-3,4-dihydroxy-(32864-11-2)

Safety Data

• Hazardous Substances Data: 32864-11-2(Hazardous Substances Data)

Upstream product

• 5417-17-4 2-chloro-3,4-dimethoxybenzaldehyde 
• 37687-57-3 2-chloro-3-hydroxy-4-methoxybenzaldehyde 
• 73894-43-6 6-Bromo-7,8-dimethoxy-1-phenyl-3-trifluoro-acetyl-2,3,4,5-tetrahydro-1H-3-benzazepine 
• 621-59-0 isovanillin 

Downstream Products

• 37687-59-5 3,4-dibenzyloxy-2-chlorobenzaldehyde 
• 110039-03-7 4-Chloro-6,7,8,9-tetrahydro-9-(4-methoxyphenyl)-5H-1,3-dioxolo<4,5-h><3>-benzazepine hydrochloride 
• 110039-00-4 α-<<<2-4-(4-Chloro-1,3-benzodioxol-5-yl)ethyl>amino>methyl>-4-methoxybenzenemethanol hydrochloride 
• 110038-81-8 6-Chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(4-methoxyphenyl)-1H-3-benzazepine hydrochloride 
• 110038-97-6 4-Chloro-N-<2-hydroxy-2-(4-methoxyphenyl)ethyl>-1,3-benzodioxole-5-acetamide 
• 959088-94-9 2-Amino-1-(3,4-bis-benzyloxy-2-chloro-phenyl)-ethanol 
• 101969-79-3 2-chloro-noradrenaline 

Relevant articles and documents

Preparation method for removing aromatic methyl ether and methyl

The invention discloses a method for removing aromatic methyl ether and methyl in synthesis of a key intermediate 2-chloro-3, 4-dihydroxybenzaldehyde of cefdinir, and belongs to the field of synthesisof medical intermediates. The method comprises the foll

Design, synthesis and biological evaluation of C(4) substituted monobactams as antibacterial agents against multidrug-resistant Gram-negative bacteria

A series of novel pyridone conjugated monobactams with various substituents at the (4) position were synthesized and evaluated for their antibacterial activities against a panel of multidrug-resistant (MDR) Gram-negative bacteria in vitro. Compounds 46d, 54 and 75e displayed good to moderate activities against P. aeruginosa, among which the activity of 75e against P. aeruginosa was comparable to that of BAL30072 under iron limitation condition. Compounds 35, 46d, 54, 56a, 56c and 56d exhibited good to excellent antibacterial activities against E. coli and K. pneumoniae, which were comparable or superior to that of BAL30072. In vitro liver microsomal stability was further evaluated and the results manifested that Compounds 35, 46d and 54 were metabolically stable in human liver microsomes.

Synthesis, renal vasodilator and dopamine-sensitive adenylate cyclase activities of O-methyl derivatives of 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepin-7,8 -diol (SK&F 82526)

-